| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 39.9 | 1853.2 | 9.6 |
| Other income | 23.7 | 1.8 | 9.1 |
| Total income | 63.6 | 1855.0 | 18.8 |
| Profit before exceptional items & tax | -20.7 | 1761.0 | -51.8 |
| Profit before tax | -20.7 | 1761.0 | -51.8 |
| Net profit | -20.8 | 1761.3 | -51.9 |
| Operating margin | -32.5% | 94.9% | -275.5% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | +315.60% |
|---|---|
| Operating profit, year on year | +27.10% |
| Operating profit, quarter on quarter | -102.50% |
Source
Read the filing ↗
BSE results filing, NSE: SPARC. Figures extracted from the filing.
Sun Pharma Advanced Research Company Ltd: key numbers
- Share price
- ₹209.05
- Market cap
- ₹6,784 Cr
- Revenue (annual)
- ₹1,879 Cr
- Net profit (annual)
- ₹1,553 Cr
- P/E (TTM)
- 4.3×Sector 50.4×
- Promoter holding
- 65.67%+0.00% QoQ
- FII holding
- 3.90%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sun Pharma Advanced Research Company Ltd
All →
20:35 IST
NSE
Financial Results
Sun Pharma Advanced Research Company Q4 FY26 Results: Turns Profitable, Net Profit ₹1,761 Cr
Sun Pharma Advanced Research Company Ltd reported revenue from operations of ₹1,853 Cr (+6713.2% YoY) and net profit of ₹1,761 Cr for Q4 FY26.
- Key figure
- Net profit ₹1,761 Cr